Profound Medical (TSE:PRN) Trading 2.1% Higher – Still a Buy?

Profound Medical Corp. (TSE:PRN) shares rose 2.1% during mid-day trading on Friday . The company traded as high as C$10.34 and last traded at C$10.25. Approximately 3,447 shares changed hands during trading, a decline of 71% from the average daily volume of 12,044 shares. The stock had previously closed at C$10.04.

Profound Medical Price Performance

The firm has a market capitalization of C$362.56 million, a P/E ratio of -7.77 and a beta of -0.91. The company has a fifty day moving average of C$9.05 and a 200 day moving average of C$8.01. The company has a debt-to-equity ratio of 20.05, a current ratio of 6.12 and a quick ratio of 14.98.

Profound Medical (TSE:PRN) last released its quarterly earnings results on Thursday, November 13th. The company reported C$0.26 earnings per share (EPS) for the quarter. The firm had revenue of C$7.36 million during the quarter. Profound Medical had a negative net margin of 349.41% and a negative return on equity of 85.22%. Sell-side analysts predict that Profound Medical Corp. will post -1.9000001 earnings per share for the current year.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.